ALLO Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03

Price $1.50

Market Cap (MRQ) $518M

P/E -1.8

EPS $-0.87

Revenue $0

ROE -59.9%

52W Range $1–$4

ALLO Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04

range

bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

10-Year Performance Revenue, net income, margins and EPS trends

06

Revenue$0

2022-12-31 → 2025-12-31

EPS$-0.87

2022-12-31 → 2025-12-31

Free Cash Flow$-150M

2023-12-31 → 2025-12-31

Net margin·

2023-12-31 → 2024-12-31

Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric	ALLO	5Y avg	Peer Median	Verdict
P/E	-1.85Y avg ≈-1.6	≈-1.6	·	·
P/B (MRQ)	1.25Y avg ≈1.1	≈1.1	4.7	Undervalued
Price / FCF (TTM)	-5.05Y avg ≈-2.2	≈-2.2	·	·
Price / Cash Flow (TTM)	-5.15Y avg ≈-2.2	≈-2.2	·	·
Price / Tangible Book	1.35Y avg ≈1.1	≈1.1	·	·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric	ALLO	5Y avg	Peer Median	Verdict
ROA	-39.6%5Y avg ≈-43.7%	≈-43.7%	-39.6%	In line
ROE	-59.9%5Y avg ≈-59.3%	≈-59.3%	-45.6%	Weak
ROIC	-71.5%	·	-35.8%	Weak

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric	5Y trend	ALLO	5Y avg	Peer Median	Verdict
Current Ratio (MRQ)		10.75Y avg ≈9.6	≈9.6	11.8	In line
Quick Ratio		1.65Y avg ≈2.0	≈2.0	11.5	Low liquidity

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric	5Y trend	ALLO	5Y avg	Peer Median	Verdict
Revenue YoY		-76.8%	·	·	·
Revenue CAGR 3Y		-94.2%	·	·	·

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric	ALLO	5Y avg	Peer Median	Verdict
EPS (Diluted)	$-0.875Y avg ≈$-1.43	≈$-1.43	·	·
Revenue / Share	$0.005Y avg ≈$0.00	≈$0.00	·	·
Cash Flow / Share	$-0.685Y avg ≈$-1.07	≈$-1.07	·	·
Cash / Share	$0.235Y avg ≈$0.36	≈$0.36	·	·

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric	5Y trend	ALLO	5Y avg	Peer Median	Verdict
Asset Turnover		0.05Y avg ≈0.0	≈0.0	0.0	Weak
Revenue / Employee		≈$0.00	·	·	·

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14

Avg Surprise 15.9%

Next Report Nov 04, 2026

Period	Report	EPS Actual	EPS Est	Surprise
June 30, 2026	Aug 12, 2026	$-0.13	$-0.17	25.5%
March 31, 2026	May 13, 2026	$-0.18	$-0.19	7.3%
Dec. 31, 2025		$-0.17	$-0.22	23.0%
Sept. 30, 2025		$-0.19	$-0.23	16.6%
June 30, 2025		$-0.23	$-0.28	17.6%
March 31, 2025		$-0.28	$-0.30	5.2%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15

Income Statement 15

Metric	2025	2024	2023	2022	2021	2020	2019
Revenue	$0	$22.0K	$95.0K	$156.0K	$114M	$0	$0
R&D Expense	$150M	$192M	$243M	$256M	$220M	$193M	$145M
SG&A Expense	$57M	$65M	$72M	$79M	$74M	$65M	$57M
Operating Expenses	$209M	$273M	$328M	$336M	$294M	$258M	$202M
Operating Income	$-209M	$-273M	$-328M	$-336M	$-180M	$-258M	$-202M
Interest Expense	·	·	·	·	·	$0	$0
Other Non-op	$215.0K	$-4M	$-18M	$-9M	$-4M	$-67M	$17M
Pretax Income	$-191M	$-257M	$-327M	·	$-257M	$-250M	$-185M
Income Tax	$0	$443.0K	$0	$0	$0	$0	$-331.0K
Net Income	$-191M	$-258M	$-327M	$-340M	$-182M	$-316M	$-185M
EPS (Basic)	$-0.87	$-1.32	$-2.09	$-2.38	$-1.34	$-2.63	$-1.83
EPS (Diluted)	$-0.87	$-1.32	$-2.09	$-2.38	$-1.34	$-2.63	$-1.83
Shares (Basic)	220,622,669	194,811,756	156,931,778	143,147,165	135,820,386	120,370,177	101,061,149
Shares (Diluted)	220,622,669	194,811,756	156,931,778	143,147,165	135,820,386	120,370,177	101,061,149
EBITDA	$-197M	$-260M	$-314M	·	$-245M	$-251M	$-197M

Balance Sheet 21

Metric	2025	2024	2023	2022	2021	2020	2019
Cash & Equivalents	$52M	$75M	$83M	$62M	$173M	$183M	$175M
Short-term Investments	·	·	·	·	$284M	$645M	$355M
Prepaid Expense	$8M	$11M	$10M	$12M	$14M	$17M	$14M
Current Assets	$258M	$303M	$459M	$529M	$471M	$845M	$545M
PP&E (Net)	$73M	$86M	$99M	$113M	$123M	$119M	$56M
PP&E (Gross)	$145M	$149M	$151M	$150M	$146M	$132M	$62M
Accum. Depreciation	$73M	$63M	$51M	$37M	$23M	$13M	$5M
Intangibles	·	·	·	·	·	$0	$151.0K
Other Non-current Assets	$4M	$2M	$7M	$10M	$6M	$5M	$5M
Total Assets	$416M	$549M	$643M	$822M	$1.05B	$1.23B	$718M
Accounts Payable	$4M	$5M	$6M	$14M	$10M	$10M	$9M
Current Liabilities	$33M	$36M	$37M	$54M	$48M	$94M	$33M
Capital Leases	$75M	$83M	$88M	$95M	$70M	$51M	$51M
Other Non-current Liabilities	$16M	$8M	$5M	$6M	$8M	$3M	$4M
Total Liabilities	$123M	$127M	$131M	$155M	$126M	$148M	$89M
Common Stock	$229.0K	$212.0K	$169.0K	$144.0K	$142.0K	$140.0K	$124.0K
Retained Earnings	$-2.01B	$-1.82B	$-1.56B	$-1.23B	$-895M	$-713M	$-396M
AOCI	$269.0K	$-89.0K	$-955.0K	$-10M	$-3M	$268.0K	$1M
Stockholders' Equity	$293M	$422M	$512M	$667M	$925M	$1.01B	$629M
Liabilities + Equity	$416M	$549M	$643M	$822M	$1.05B	$1.23B	$718M
Shares Outstanding	229,413,523	212,210,597	168,642,238	144,438,304	142,623,065	140,474,305	124,267,358

Cash Flow 15

Metric	2025	2024	2023	2022	2021	2020	2019
D&A	$12M	$14M	$14M	$14M	$10M	$7M	$5M
Stock-based Comp	$38M	$52M	$66M	$84M	$81M	$65M	$46M
Deferred Tax	$0	$443.0K	$0	·	·	·	·
Amort. of Intangibles	·	·	·	$0	$0	$151.0K	$603.0K
Restructuring	$5M	·	·	·	·	·	·
Other Non-cash	$-8M	$-9M	$9M	·	$-19M	$62M	$-3M
Operating Cash Flow	$-149M	$-200M	$-238M	$-221M	$-185M	$-115M	$-137M
CapEx	$386.0K	$694.0K	$2M	$5M	$21M	$66M	$51M
Investing Cash Flow	$96M	$76M	$163M	$106M	$164M	$-505M	$164M
Stock Issued	·	·	$91M	$0	$0	$596M	$0
Net Stock Activity	·	·	$91M	·	$0	$622M	$54M
Financing Cash Flow	$30M	$117M	$96M	$3M	$12M	$634M	$59M
Net Change in Cash	$-24M	$-8M	$21M	$-111M	$-9M	$13M	$86M
Free Cash Flow	$-150M	$-201M	$-239M	·	$-206M	$-181M	$-188M
Levered FCF	·	·	·	·	·	$-181M	$-188M

Profitability 7

Metric	2025	2024	2023	2022	2021	2020	2019
Operating Margin	·	-1241813.6%	-344986.3%	·	-664.6%	·	·
Net Margin	·	-1170863.6%	-344489.5%	·	-667.7%	·	·
Pretax Margin	·	-1168850.0%	·	·	-667.7%	·	·
EBITDA Margin	·	-1179818.2%	-330039.0%	·	-637.3%	·	·
ROA	-39.6%	-43.2%	-48.3%	·	-22.7%	-25.7%	-24.8%
ROE	-59.9%	-58.1%	-59.9%	·	-27.3%	-22.8%	-29.6%
ROIC	-71.5%	-64.8%	·	·	-27.9%	-23.9%	-32.1%

Liquidity & Solvency 2

Metric	Trend	2025	2024	2023	2022	2021	2020	2019
Current Ratio		7.9	8.5	12.4	·	9.8	9.0	16.5
Quick Ratio		1.6	2.1	2.2	·	9.5	8.8	16.0

Efficiency 1

Metric	Trend	2025	2024	2023	2022	2021	2020	2019
Asset Turnover		0.0	0.0	0.0	·	0.0	·	·

Per Share 6

Metric	2025	2024	2023	2022	2021	2020	2019
Book Value / Share	$1.28	$1.99	$3.04	·	$6.43	$7.69	$5.06
Revenue / Share	$0.00	$0.00	$0.00	·	$0.28	·	·
Cash Flow / Share	$-0.68	$-1.03	$-1.51	·	$-1.36	·	·
Cash / Share	$0.23	$0.35	$0.49	·	$1.22	$1.31	$1.41
Dividend / Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
EPS (TTM)	$-0.87	$-1.32	$-2.09	$-2.38	$-1.34	$-2.63	$-1.83

Growth Rates 2

Metric	Trend	2025	2024	2023	2022	2021	2020	2019
Revenue YoY		·	-76.8%	-39.1%	-99.9%	·	·	·
Revenue CAGR 3Y		·	-94.2%	·	·	·	·	·

Valuation (TTM) 10

Metric	2025	2024	2023	2022	2021	2020	2019
Revenue TTM	$0	$22.0K	$95.0K	$156.0K	$114M	$0	$0
Net Income TTM	$-191M	$-258M	$-327M	$-340M	$-182M	$-316M	$-185M
Market Cap	$314M	$452M	$541M	·	$2.13B	$3.55B	$3.23B
P/E	-1.6	-1.6	-1.5	-2.6	-11.1	-9.6	-14.2
P/S	·	20545.8	5698.3	·	18.7	·	·
P/B	1.1	1.1	1.1	·	2.3	3.3	5.1
P / Tangible Book	1.1	1.1	1.1	1.4	2.3	3.5	·
P / Cash Flow	-2.1	-2.3	-2.3	·	-11.5	-30.8	-23.5
P / FCF	-2.1	-2.2	-2.3	·	-10.3	-19.6	-17.2
Earnings Yield	-63.5%	-62.0%	-65.1%	-37.8%	-9.0%	-10.4%	-7.0%

Income Statement 12

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$5M	·	$0	$0	$0	$0	$0	$0	$0	$22.0K	$21.0K	$22.0K	$22.0K	$30.0K	$-40.0K	$27.0K
R&D Expense	$31M	$32M	$29M	$31M	$40M	$50M	$45M	$45M	$50M	$52M	$55M	$46M	$62M	$80M	$75M	$64M
SG&A Expense	$21M	$14M	$14M	$14M	$14M	$15M	$16M	$16M	$16M	$17M	$17M	$17M	$19M	$19M	$21M	$19M
Operating Expenses	$52M	$46M	$42M	$45M	$57M	$65M	$60M	$72M	$71M	$70M	$85M	$63M	$81M	$99M	$96M	$83M
Operating Income	$-47M	$-46M	$-42M	$-45M	$-57M	$-65M	$-60M	$-72M	$-71M	$-70M	$-85M	$-63M	$-81M	$-99M	$-96M	$-83M
Other Non-op	$-61.0K	$212.0K	$247.0K	$-81.0K	$-43.0K	$92.0K	$-2M	$-1M	$85.0K	$-929.0K	$-12M	$-5M	$-2M	$2M	$-10M	$-3M
Net Income	$-43M	$-43M	$-39M	$-41M	$-51M	$-60M	$-60M	$-66M	$-66M	$-65M	$-86M	$-62M	$-79M	$-100M	$-103M	$-84M
EPS (Basic)	$-0.13	$-0.18	$-0.17	$-0.19	$-0.23	$-0.28	$-0.27	$-0.32	$-0.35	$-0.38	$-0.49	$-0.37	$-0.54	$-0.69	$-0.72	$-0.59
EPS (Diluted)	$-0.13	$-0.18	$-0.17	$-0.19	$-0.23	$-0.28	$-0.27	$-0.32	$-0.35	$-0.38	$-0.49	$-0.37	$-0.54	$-0.69	$-0.72	$-0.59
Shares (Basic)	328,930,269	240,290,782	·	222,038,680	218,929,548	215,358,619	·	209,188,551	190,026,638	169,128,362	·	167,649,010	146,795,826	144,563,829	·	143,661,721
Shares (Diluted)	328,930,269	240,290,782	·	222,038,680	218,929,548	215,358,619	·	209,188,551	190,026,638	169,128,362	·	167,649,010	146,795,826	144,563,829	·	143,661,721
EBITDA	$-47M	$-43M	·	$-45M	$-57M	$-62M	·	$-72M	$-71M	$-70M	·	$-63M	$-81M	$-99M	·	$-82M

Balance Sheet 19

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$39M	$30M	$52M	$38M	$52M	$42M	$75M	$51M	$171M	$51M	$83M	$69M	$155M	$110M	$62M	$74M
Prepaid Expense	$7M	$6M	$8M	$9M	$10M	$12M	$11M	$13M	$12M	$11M	$10M	$8M	$10M	$10M	$12M	$17M
Current Assets	$340M	$273M	$258M	$261M	$283M	$292M	$303M	$304M	$457M	$395M	$459M	$473M	$502M	$481M	$529M	$569M
PP&E (Net)	$67M	$70M	$73M	$76M	$79M	$83M	$86M	$89M	$92M	$96M	$99M	$103M	$106M	$110M	$113M	$114M
PP&E (Gross)	$145M	$145M	$145M	$145M	$146M	$149M	$149M	$149M	$148M	$151M	$151M	$150M	$150M	$150M	$150M	$149M
Accum. Depreciation	$78M	$75M	$73M	$70M	$67M	$66M	$63M	$60M	$56M	$55M	$51M	$48M	$44M	$40M	$37M	$35M
Other Non-current Assets	$4M	$4M	$4M	$4M	$4M	$2M	$2M	$5M	$6M	$5M	$7M	$10M	$9M	$9M	$10M	$9M
Total Assets	$550M	$396M	$416M	$440M	$471M	$508M	$549M	$589M	$647M	$586M	$643M	$712M	$771M	$747M	$822M	$888M
Accounts Payable	$6M	$5M	$4M	$4M	$5M	$5M	$5M	$6M	$13M	$6M	$6M	$6M	$10M	$15M	$14M	$11M
Current Liabilities	$32M	$28M	$33M	$32M	$32M	$30M	$36M	$33M	$37M	$31M	$37M	$38M	$55M	$60M	$54M	$49M
Capital Leases	$70M	$73M	$75M	$77M	$79M	$81M	$83M	$85M	$87M	$89M	$88M	$90M	$92M	$94M	$95M	$97M
Other Non-current Liabilities	$12M	$16M	$16M	$15M	$15M	$11M	$8M	$8M	$8M	$5M	$5M	$1M	$2M	$2M	$6M	$2M
Total Liabilities	$114M	$117M	$123M	$124M	$126M	$123M	$127M	$125M	$132M	$125M	$131M	$129M	$148M	$155M	$155M	$148M
Common Stock	$345.0K	$245.0K	$229.0K	$223.0K	$220.0K	$219.0K	$212.0K	$210.0K	$209.0K	$170.0K	$169.0K	$168.0K	$167.0K	$146.0K	$144.0K	$144.0K
Retained Earnings	$-2.10B	$-2.05B	$-2.01B	$-1.97B	$-1.93B	$-1.88B	$-1.82B	$-1.76B	$-1.69B	$-1.63B	$-1.56B	$-1.47B	$-1.41B	$-1.33B	$-1.23B	$-1.14B
AOCI	$-518.0K	$-183.0K	$269.0K	$235.0K	$-45.0K	$43.0K	$-89.0K	$157.0K	$-780.0K	$-927.0K	$-955.0K	$-2M	$-4M	$-6M	$-10M	$-13M
Stockholders' Equity	$436M	$279M	$293M	$315M	$345M	$385M	$422M	$464M	$515M	$461M	$512M	$583M	$623M	$592M	$667M	$740M
Liabilities + Equity	$550M	$396M	$416M	$440M	$471M	$508M	$549M	$589M	$647M	$586M	$643M	$712M	$771M	$747M	$822M	$888M
Shares Outstanding	345,345,427	244,816,413	229,413,523	223,163,672	220,133,876	218,598,262	212,210,597	209,500,137	209,049,485	170,452,967	168,642,238	168,175,221	167,133,664	145,740,333	144,438,304	144,031,588

Cash Flow 12

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$4M	$4M	$3M	$4M	·	·	·	·
Stock-based Comp	$12M	$8M	$8M	$9M	$9M	$12M	$13M	$13M	$14M	$12M	$15M	$15M	$17M	$19M	$17M	$21M
Restructuring	·	·	$0	$0	·	·	·	·	·	·	·	·	·	·	·	·
Other Non-cash	·	$19M	·	·	·	$-8M	·	·	·	·	·	·	·	·	·	·
Operating Cash Flow	$-32M	$-13M	$-28M	$-30M	$-39M	$-53M	$-37M	$-44M	$-64M	$-56M	$-54M	$-56M	$-62M	$-67M	$-62M	$-48M
CapEx	$150.0K	$9.0K	$0	$243.0K	$44.0K	$99.0K	$257.0K	$429.0K	$0	$8.0K	$181.0K	$12.0K	$288.0K	$1M	$2M	$223.0K
Investing Cash Flow	$-148M	$-30M	$34M	$12M	$44M	$6M	$55M	$-76M	$75M	$22M	$67M	$-34M	$17M	$113M	$50M	$25M
Stock Issued	·	·	·	·	·	$10M	·	·	·	$0	·	$3M	·	·	$0	$0
Net Stock Activity	·	·	·	·	·	$10M	·	·	·	·	·	·	·	·	·	·
Financing Cash Flow	$188M	$21M	$8M	$3M	$5M	$14M	$6M	$679.0K	$109M	$2M	$155.0K	$4M	$90M	$2M	$46.0K	$1M
Net Change in Cash	$8M	$-21M	$14M	$-15M	$10M	$-33M	$24M	$-119M	$120M	$-32M	$14M	$-86M	$45M	$48M	$-12M	$-22M
Free Cash Flow	·	$-13M	·	·	·	$-53M	·	·	·	$-56M	·	·	·	$-68M	·	·

Profitability 5

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-1011.2%	·	·	·	·	·	·	·	·	-315927.3%	·	-146453.5%	-182995.5%	-190519.2%	·	-168344.9%
Net Margin	-919.8%	·	·	·	·	·	·	·	·	-295454.6%	·	-142593.0%	-177247.7%	-189815.4%	·	-169689.8%
EBITDA Margin	-1011.2%	·	·	·	·	·	·	·	·	-315927.3%	·	-146453.5%	-182995.5%	-190519.2%	·	-168344.9%
ROA	-8.4%	-9.4%	·	-8.1%	-9.1%	-10.9%	·	-10.2%	-9.4%	-9.8%	·	-7.7%	-9.1%	-11.5%	·	-8.5%
ROE	-10.9%	-12.8%	·	-10.6%	-11.8%	-14.1%	·	-12.7%	-11.7%	-12.3%	·	-9.3%	-10.9%	-13.6%	·	-9.7%

Liquidity & Solvency 2

Metric	Trend	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio		10.7	9.6	·	8.2	8.9	9.7	·	9.3	12.3	12.8	·	12.6	9.2	8.1	·	11.6
Quick Ratio		1.2	1.1	·	1.2	1.7	1.4	·	1.6	4.6	1.7	·	1.8	2.8	1.8	·	1.5

Efficiency 1

Metric	Trend	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.0	·	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.0

Per Share 5

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$1.26	$1.14	·	$1.41	$1.57	$1.76	·	$2.21	$2.46	$2.71	·	$3.47	$3.73	$4.06	·	$5.14
Revenue / Share	$0.01	·	·	$0.00	$0.00	$0.00	·	$0.00	$0.00	$0.00	·	$0.00	$0.00	$0.00	·	$0.00
Cash Flow / Share	·	$-0.05	·	·	·	$-0.25	·	·	·	$-0.33	·	·	·	$-0.46	·	·
Cash / Share	$0.11	$0.12	·	$0.17	$0.24	$0.19	·	$0.24	$0.82	$0.30	·	$0.41	$0.93	$0.75	·	$0.52
EPS (TTM)	$-0.67	$-0.77	·	$-0.97	$-1.10	$-1.22	·	$-1.54	$-1.59	$-1.78	·	$-2.32	$-2.54	$-2.56	·	$-1.70

Valuation (TTM) 9

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	·	$0	·	$0	$0	$0	·	$43.0K	$65.0K	$87.0K	·	$34.0K	$39.0K	$81.0K	·	$76M
Net Income TTM	$-165M	$-174M	·	$-212M	$-237M	$-252M	·	$-283M	$-279M	$-292M	·	$-344M	$-366M	$-367M	·	$-243M
Market Cap	$718M	$597M	·	$277M	$249M	$319M	·	$587M	$487M	$762M	·	$533M	$831M	$720M	·	$1.56B
P/E	-3.1	-3.2	·	-1.3	-1.0	-1.2	·	-1.8	-1.5	-2.5	·	-1.4	-2.0	-1.9	·	-6.4
P/S	·	·	·	·	·	·	·	13641.9	7493.6	8757.8	·	15679.9	21298.8	8888.4	·	20.5
P/B	1.6	2.1	·	0.9	0.7	0.8	·	1.3	0.9	1.7	·	0.9	1.3	1.2	·	2.1
P / Tangible Book	1.6	2.1	·	0.9	0.7	0.8	·	1.3	0.9	1.7	·	0.9	1.3	1.2	·	2.1
P / Cash Flow	·	-46.3	·	·	·	-6.0	·	·	·	-13.6	·	·	·	-10.8	·	·
Earnings Yield	-32.2%	-31.6%	·	-78.2%	-97.4%	-83.6%	·	-55.0%	-68.2%	-39.8%	·	-73.2%	-51.1%	-51.8%	·	-15.7%

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16

Metric	2025-12-31	2024-12-31	2023-12-31	2023-09-30	2023-06-30
Revenue	$0	$22.0K	$95.0K	·	·
Operating Margin %	·	-1241813.6%	-344986.3%	·	·
Net Income	$-191M	$-258M	$-327M	·	·
Diluted EPS	$-0.87	$-1.32	$-2.09	·	·

Metric	2025-12-31	2024-12-31	2023-12-31	2023-09-30	2023-06-30
Current Ratio	7.9	8.5	12.4	·	·
Quick Ratio	1.6	2.1	2.2	·	·

Metric	2025-12-31	2024-12-31	2023-12-31	2023-09-30	2023-06-30
Free Cash Flow	$-150M	$-201M	$-239M	·	·

Institutional owners (13F) 228 filers · $652.3M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 228

Value held $652.3M

New positions 34

Exited positions 27

Institutional activity — Q2 2026 vs prior quarter

New positions	Exited positions	Increased	Decreased	Net shares change
34 (-18 vs prior Q)	27 (+16 vs prior Q)	100 (+19 vs prior Q)	51 (+10 vs prior Q)	+129.2M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution	Value	Shares	% of tracked 13F	Type
BlackRock, Inc.	$62,705,681	30,146,963	9.61%	Shares
Pfizer Inc	$46,928,245	22,032,040	7.19%	Shares
Frazier Life Sciences Management, L.P.	$46,689,069	22,446,668	7.16%	Shares
STATE STREET CORP	$39,573,718	19,025,826	6.07%	Shares
TPG GP A, LLC	$38,929,916	18,716,306	5.97%	Shares
Sio Capital Management, LLC	$27,712,736	13,323,431	4.25%	Shares
PRIMECAP MANAGEMENT CO/CA/	$27,296,756	13,123,440	4.18%	Shares
VANGUARD CAPITAL MANAGEMENT LLC	$25,306,603	12,166,636	3.88%	Shares
FMR LLC	$24,978,809	12,009,043	3.83%	Shares
CITADEL ADVISORS LLC	$20,982,562	10,087,770	3.22%	Shares
TWO SIGMA INVESTMENTS, LP	$16,191,444	7,784,348	2.48%	Shares
GEODE CAPITAL MANAGEMENT, LLC	$14,666,040	7,049,328	2.25%	Shares
GOLDMAN SACHS GROUP INC	$12,789,834	6,148,959	1.96%	Shares
VANGUARD GROUP INC	$12,674,704	9,251,609	1.94%	Shares
GordonMD Global Investments LP	$11,019,840	5,298,000	1.69%	Shares
MARSHALL WACE, LLP	$10,598,449	5,095,408	1.62%	Shares
Patient Square Capital LP	$10,504,000	5,050,000	1.61%	Shares
Aberdeen Group plc	$10,403,644	5,001,752	1.60%	Shares
MILLENNIUM MANAGEMENT LLC	$10,075,289	4,843,889	1.54%	Shares
D. E. Shaw & Co., Inc.	$9,798,329	4,710,735	1.50%	Shares
MORGAN STANLEY	$9,380,720	4,509,962	1.44%	Shares
Woodline Partners LP	$9,361,298	4,500,624	1.44%	Shares
Candriam S.C.A.	$9,010,818	4,336,296	1.38%	Shares
VANGUARD PORTFOLIO MANAGEMENT LLC	$8,761,122	4,212,078	1.34%	Shares
RENAISSANCE TECHNOLOGIES LLC	$7,975,369	3,834,312	1.22%	Shares
Walleye Capital LLC	$6,797,465	3,268,012	1.04%	Shares
RTW INVESTMENTS, LP	$6,760,000	3,250,000	1.04%	Shares
DIMENSIONAL FUND ADVISORS LP	$6,740,207	3,239,077	1.03%	Shares
BANK OF AMERICA CORP /DE/	$6,629,626	3,187,320	1.02%	Shares
UBS Group AG	$6,319,855	3,038,392	0.97%	Shares
Ghisallo Capital Management LLC	$6,240,000	3,000,000	0.96%	Shares
NORTHERN TRUST CORP	$6,146,986	2,955,282	0.94%	Shares
Wildcat Capital Management, LLC	$6,075,237	2,920,787	0.93%	Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$4,730,675	2,274,363	0.73%	Shares
AQR CAPITAL MANAGEMENT LLC	$4,173,079	2,006,288	0.64%	Shares
DAFNA Capital Management LLC	$4,160,000	2,000,000	0.64%	Shares
TWO SIGMA ADVISERS, LP	$3,959,574	2,890,200	0.61%	Shares
VANGUARD FIDUCIARY TRUST CO	$3,823,756	1,838,344	0.59%	Shares
JPMORGAN CHASE & CO	$3,193,323	1,438,434	0.49%	Shares
Boxer Capital Management, LLC	$3,120,000	1,500,000	0.48%	Shares
JACOBS LEVY EQUITY MANAGEMENT, INC	$3,026,614	1,455,103	0.46%	Shares
Raiffeisen Bank International AG	$2,442,000	1,100,000	0.37%	Shares
Vida Ventures Advisors, LLC	$2,229,722	1,798,163	0.34%	Shares
Invesco Ltd.	$1,607,395	772,786	0.25%	Shares
Bank of New York Mellon Corp	$1,512,540	727,182	0.23%	Shares
Man Group plc	$1,459,954	701,901	0.22%	Shares
RAYMOND JAMES FINANCIAL INC	$1,412,262	678,972	0.22%	Shares
Nuveen, LLC	$1,299,268	624,648	0.20%	Shares
IEQ CAPITAL, LLC	$1,207,172	580,371	0.19%	Shares
Mitsubishi UFJ Asset Management Co., Ltd.	$1,138,153	547,189	0.17%	Shares

Show all 228 institutional owners →

Activists & 5%+ owners 6 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer	Filed	Stake	Status	Purpose	Filing
James G. Coulter, Jon Winkelried, TPG GP A, LLC	Sept. 30, 2026	0.00%	Amendment	·	SEC
Pfizer Inc.	Feb. 13, 2026	9.00%	Amendment	·	SEC
Pfizer Inc. (“Pfizer”) ×3 filings	Oct. 25, 2023	·	Initial filing	·	SEC
TPG GP A, LLC, David Bonderman, James G. Coulter, Jon Winkelried	Jan. 18, 2022	·	Initial filing	·	SEC
TPG Group Holdings (SBS) Advisors, Inc., David Bonderman, James G. Coulter ×4 filings	Aug. 10, 2020	·	Initial filing	·	SEC
Pfizer Inc. (“ Pfizer ”)	Oct. 22, 2018	·	Initial filing	Passive investment	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 23 insiders · 13 officers · 8 directors

19

Insider	Role	Last activity	Shares owned	Sells 12m	Net 12m
Zachary Roberts	President and CEO	July 1, 2026 A	581,166	2	$-104,169
David D Chang	President and CEO	March 16, 2026 S	5,150,599	2	$-289,459
Geoffrey M. Parker	CHIEF FINANCIAL OFFICER	Feb. 2, 2026 A	1,252,795	2	$-88,539
Eric Thomas Schmidt	Chief Financial Officer	March 22, 2023 A	862,439	0	$0
Earl Martin Douglas	SVP, General Counsel	Aug. 21, 2026 S	488,267	2	$-103,262
Annie Yoshiyama	SVP, Finance	April 21, 2026 S	124,517	2	$-29,311
Benjamin Machinas Beneski	SVP, Chief Technical Officer	March 31, 2026 S	195,338	5	$-51,672
Timothy L. Moore	Chief Technical Officer	Feb. 3, 2025 S	250,713	0	$0
Yinlin Jack Chen	SVP, Finance	Aug. 10, 2023 A	88,881	0	$0
Lillian Smith	VP, Corporate Counsel	April 1, 2023 A	140,390	0	$0
Alison Moore	Chief Technical Officer	March 22, 2023 A	672,731	0	$0
Veer Bhavnagri	General Counsel	March 14, 2023 F	556,049	0	$0
Rafael Amado	EVP of R&D	Oct. 7, 2022 F	541,946	0	$0
Stephen Mayo	Director	June 18, 2026 A	25,328	0	$0
Elizabeth A. Barrett	Director	June 18, 2026 A	·	0	$0
Deborah M. Messemer	Director	June 18, 2026 A	107,431	0	$0
Owen N. Witte	Director	June 18, 2026 A	292,832	0	$0
Franz B Humer	Director	June 18, 2026 A	307,507	0	$0
Joshua A Kazam	Director	June 18, 2026 A	398,463	0	$0
Vicki L Sato	Director	June 18, 2026 A	162,575	0	$0
PF Equity Holdings 2 B.V.	10% owner	March 31, 2022 J	0	0	$0
Pfizer Inc.	10% owner	Oct. 15, 2018 C	22,032,040	0	$0
Arie Belldegrun	·	Feb. 2, 2026 A	2,236,816	0	$0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 22 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund	Weight	Units	As of	Source
BBC · ETFis Series Trust I	0.66%	163,586 NS	July 31, 2026	N-PORT
LABU · Direxion Shares ETF Trust	0.16%	412,615 NS	July 31, 2026	N-PORT
VFMO · VANGUARD WELLINGTON FUND	0.05%	496,849 SH	Aug. 19, 2026	Daily
PWS · Pacer Funds Trust	0.04%	5,637 NS	July 31, 2026	N-PORT
VTWV · VANGUARD SCOTTSDALE FUNDS	0.04%	231,043 SH	Aug. 19, 2026	Daily
PRFZ · Invesco Exchange-Traded Fund Trust	0.04%	671,465 SH	Oct. 2, 2026	Daily
IBBQ · Invesco Exchange-Traded Fund Trust …	0.04%	24,445 SH	Oct. 2, 2026	Daily
IBB · iShares Trust	0.03%	1,977,547 SH	Sept. 11, 2026	Daily
VTWO · VANGUARD SCOTTSDALE FUNDS	0.02%	1,528,157 SH	Aug. 19, 2026	Daily
OMFS · Invesco Exchange-Traded Self-Indexe…	0.02%	27,831 SH	Oct. 2, 2026	Daily
IWM · iShares Trust	0.02%	6,789,955 SH	Sept. 11, 2026	Daily
DFAS · Dimensional ETF Trust	0.01%	1,028,485 NS	July 31, 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0.01%	3,222,860 SH	Aug. 19, 2026	Daily
VHT · VANGUARD WORLD FUND	0.01%	776,881 SH	Aug. 19, 2026	Daily
DFAC · Dimensional ETF Trust	0.00%	241,276 NS	July 31, 2026	N-PORT
ITOT · iShares Trust	0.00%	356,622 SH	Sept. 11, 2026	Daily
DFUS · Dimensional ETF Trust	0.00%	71,758 NS	July 31, 2026	N-PORT
IWV · iShares Trust	0.00%	25,550 SH	Sept. 3, 2026	Daily
VTI · VANGUARD INDEX FUNDS	0.00%	8,666,591 SH	Aug. 19, 2026	Daily
VTHR · VANGUARD SCOTTSDALE FUNDS	0.00%	22,307 SH	Aug. 19, 2026	Daily
IWN · iShares Trust	·	2,464,664 SH	Sept. 11, 2026	Daily
SMLF · iShares Trust	·	484,475 SH	Sept. 11, 2026	Daily

ALLO Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21

rating · 18 analysts BUY

Median target $9.00 +500.0%

6 33.3% Strong Buy

10 55.6% Buy

2 11.1% Hold

0 0.0% Sell

0 0.0% Strong Sell

12-Month Price Target

9 analysts · 2026-10-03

Mean target $9.00 +500.0%

← Below all targets Current price $1.50

Low$4.00 Mean$9.00 High$14.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker	Market Cap	P/E	Rev YoY	Net Margin	ROE	Gross Margin
ALLO	$314M	-1.6	-76.8%	·	-59.9%	·
SGMT	·	-3.7	·	·	-42.3%	·
CTMX	$725M	·	-44.8%	-22.8%	-15.9%	·
PRME	$626M	-2.6	55.3%	-4342.4%	-221.4%	·
ALT	$400M	-3.6	105.0%	-214861.0%	-45.6%	·
MPLT	$773M	-0.9	·	·	-151.1%	·
MNPR	·	·	·	·	·	·
CBIO	$327M	-24.2	-86.7%	-1419.6%	-90.0%	·
NGNE	$319M	-4.9	·	·	-33.6%	·
ZURA	·	·	·	·	·	·
CAPR	$1.66B	-12.8	-11.6%	·	-51.1%	·

Latest News Recent headlines mentioning this company

23

Allogene Therapeutics (ALLO): 10 Best Growth Stocks Under $10 to Invest In Yahoo Finance · 5 months, 1 week ago

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

ALLO Allogene Therapeutics, Inc. - Common Stock